Sign in

CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824151574
Phone
(877) 742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
  1. SC 13D/A Stake Beneficial Ownership Report
  2. 10-K Report Annual Report
  3. 8-K Event Results of operations
  4. 4 Open-market sale President and Chief Executive sold 11,513 shares at an average $43.32 ($498,751)
  5. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  6. 4 Open-market sale 10% owner sold 710,000 shares at $43.75 ($31,062,500)
  7. 4 Open-market sale Director sold 55,000 shares at an average $47.58 ($2,617,090)
  8. 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $45.88 ($665,290)
  9. 4 Open-market sale Director sold 70,000 shares at an average $46.49 ($3,254,612)
  10. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  11. SC 13G/A Stake Amended Statement of Ownership
  12. 5 Insider Annual Insider Trading Report
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 4 Open-market sale Chief Operating Officer sold 14,500 shares at an average $39.89 ($578,441)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 20 of 25 · 496 filings